New Hope in Fight Against Advanced Lung Cancer
Basel, Switzerland (ots/PRNewswire) - - Roche files marketing application for Tarceva with European health authorities Roche today submitted a Marketing Authorisation Application to the European health authorities for its new cancer drug Tarceva (erlotinib) for the treatment of advanced non-small cell lung cancer (NSCLC). NSCLC is the most common form of lung cancer, which in itself is the most frequent cancer ...
mehr